reference/9205910

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9205910

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Controlled Clinical Trial\|Journal Article
endingPage	195
issn	1421-9662 0001-5792
issueIdentifier	4
pageRange	189-195
publicationName	Acta Haematologica
startingPage	189
bibliographicCitation	Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. Acta Haematol. 2004;111(4):189–95. doi: 10.1159/000077551. PMID: 15153710.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84ed55cf9d82d982a84ed03d976f27d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ccfb57a3fb17488744c37b2314720bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16fe0927e992733bfe27006cd71967f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d58c03e82d95871c2bb87039d2628d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc584f28b0b006987cea48edb8747bbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c54df0c42ab920933f85922b22bdde4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c44f2d39866a545c8a7d9d34d4750cc
date	2004
identifier	https://pubmed.ncbi.nlm.nih.gov/15153710 https://doi.org/10.1159/000077551
isPartOf	https://portal.issn.org/resource/ISSN/0001-5792 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/76 https://portal.issn.org/resource/ISSN/1421-9662
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules
discusses	http://id.nlm.nih.gov/mesh/M0028782 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0024220 http://id.nlm.nih.gov/mesh/M0008402 http://id.nlm.nih.gov/mesh/M0018636 http://id.nlm.nih.gov/mesh/M0028429 http://id.nlm.nih.gov/mesh/M0007726 http://id.nlm.nih.gov/mesh/M0028145 http://id.nlm.nih.gov/mesh/M0010133
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017086Q000188 http://id.nlm.nih.gov/mesh/D001803Q000706 http://id.nlm.nih.gov/mesh/D004921Q000008 http://id.nlm.nih.gov/mesh/D015815Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019334Q000187 http://id.nlm.nih.gov/mesh/D011990Q000097 http://id.nlm.nih.gov/mesh/D019040Q000097 http://id.nlm.nih.gov/mesh/D012995 http://id.nlm.nih.gov/mesh/D011994 http://id.nlm.nih.gov/mesh/D005319Q000032 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006454Q000187 http://id.nlm.nih.gov/mesh/D011990Q000187 http://id.nlm.nih.gov/mesh/D015815Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006454Q000032 http://id.nlm.nih.gov/mesh/D005319Q000187 http://id.nlm.nih.gov/mesh/D019334Q000097 http://id.nlm.nih.gov/mesh/D017086Q000150 http://id.nlm.nih.gov/mesh/D017086Q000628 http://id.nlm.nih.gov/mesh/D019040Q000187 http://id.nlm.nih.gov/mesh/D018799Q000097 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018799Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b88d5e2508c1ccf58e9fddfe115c0ae http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9971 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2973 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2972 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7982 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4ad2f9eb2c6b36b6c74ff941fefb834b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10737 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a508191c8cebe0acae85fc38c424848c

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129345290 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129338095

Total number of triples: 75.